-
The Bulky Size of SARS-CoV-2 Might Make the Antibodies of Vaccine Ineffective
PharmaSources/Professor in Medical Field
June 16, 2021
Coronavirus is a positive-sense single-stranded RNA virus with a thick envelope, which has the largest genetic material among all the RNA viruses, and it is a key pathogen for many diseases of domestic animals, pets and human.
-
The Pharmaceutical Industry is Proving its Resilience Amid the COVID-19 Pandemic
Deborah Seah
May 31, 2021
In the past year, the pharmaceutical industry has been in the limelight amid the COVID-19 pandemic.
-
Artificial Intelligence and COVID-19 Vaccines
Lin Zhang
May 31, 2021
In recent years, AI, in general, is becoming a popular tool in the pharmaceutical industry, not just in the case of COVID specifically.
-
A Review of the Current Situation of COVID-19 R&D in China with Two More COVID-19 Vaccines Marketed
PharmaSources/Yefenghong
May 31, 2021
On Feb. 25, the National Medical Products Administration of China (NMPA) conditionally approved the registration applications of two COVID-19 vaccines: Inactivated COVID-19 Vaccine (Vero Cell) of Sinopharm Wuhan Institute of Biological Products Co., Ltd.
-
FDA Fast Track for New Vaccine During COVID-19 Pandemic
Lin Zhang
May 26, 2020
The world has never faced a crisis like COVID-19 (SARS-CoV-2), a pandemic health emergency. As of May 7, 2020, there are over 3.6 million cases (70,581+ new) and over 251,446 deaths of COVID-19 worldwide.
-
Decentralized Clinical Trials— The Tomorrow of Clinical Research
Lin Zhang
April 07, 2021
The Coronavirus disease 2019 (COVID-19) pandemic has led to many changes in the way different processes are handled. In particular, it is profoundly disrupting clinical research.
-
A Brief Overview of COVID-19 Pandemic in 2020
Lin Zhang
March 18, 2021
2020 has been a challenging year across the globe. SARS-CoV-2, the virus that causes COVID-19 and is believed to originate from bats, quickly spread into a global pandemic.
-
Notable Vaccines Against COVID-19 Making Promising Progress
Deborah Seah
March 18, 2021
The year 2020 has proven to be a defining year for the medical and biopharmaceutical fields across the world. Since the first half of the year, many countries across the world have been plagued with the COVID-19 pandemic.
-
Rolling out the vaccines
Sarah Harding
March 18, 2021
The UK became the first country to approve the Pfizer/BioNTech vaccine on 2nd December last year, swiftly followed by the US, the EU, and other countries across the world.
-
Tackling Substandard and Falsified Medical Products
Shem Oirere
March 03, 2021
The outbreak and spread of COVID-19 could exacerbate Africa’s persistent challenge of production, importation and distribution of substandard and falsified medical products.